Table 3.

Multivariable linear regression for the association between MVPA and echocardiogram measures

Outcome	Model 1	Model 2	Model 3
LVMI, g/m2	0.0411	0.1318	0.1381
LVMI2.7/EDV	−0.0014	−0.0006	−0.0006
RWT, ratio	−0.0005	−0.0001	0.0001
LAVI, mL/m2	0.1707*	0.1808*	0.1792*
EF, %	0.0578	0.0448	0.0389
E/e′, ratio	0.0037	0.0221	0.0259
GLS, %	−0.069	−0.0521	−0.0539
GCS, %	−0.2477*	−0.2397*	−0.2397*
SV, mL	0.3277	0.3177	0.3174
RV peak S, cm/s	0.0589	0.0590	0.0615
RV FAC, %	0.0021	0.0019	0.0019
TRV Max, cm/s	1.1367	1.1386	1.1597
TAPSE, cm	0.0084	0.0082	0.0078

M1: demographics (age and sex).

M2: M1+systolic blood pressure, antihypertensive med use.

M3: M2+other cardiovascular disease modifiable factors (diabetes mellitus, current smoking and high-density lipoprotein).

Values are per 10 min/day light MVPA.

*P value <0.01.

E, peak early diastolic transmitral inflow velocities; EDV, end diastolic volume; e′, average of mitral early diastolic septal and lateral annular velocities; EF, ejection fraction; GCS, global circumferential strain; GLS, global longitudinal strain; LAVI, left atrial volume index; LVMI, left ventricular mass index; M, model; MVPA, moderate to vigorous PA; RV, right ventricular; RV FAC, RV fractional area change; RWT, relative valve thickness; SV, stroke volume; TAPSE, tricuspid annular plane systolic excursion; TRV, tricuspid regurgitation velocity.